메뉴 건너뛰기




Volumn 7, Issue 12, 2014, Pages 8770-8776

Increased expression of stanniocalcin 2 is associated with tumor progression after radiotherapy in patients with cervical carcinoma

Author keywords

Cervical cancer; Prognosis; Radiotherapy; Stanniocalcin 2

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GLYCOPROTEIN; SIGNAL PEPTIDE; STC2 PROTEIN, HUMAN; TUMOR MARKER;

EID: 84921508970     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (21)
  • 1
    • 84866626878 scopus 로고    scopus 로고
    • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • vii27-32
    • Colombo N, Carinelli S, Colombo A, Marini C, Rollo D and Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7: vii27-32.
    • (2012) Ann Oncol , vol.23
    • Colombo, N.1    Carinelli, S.2    Colombo, A.3    Marini, C.4    Rollo, D.5    Sessa, C.6
  • 4
    • 0032566015 scopus 로고    scopus 로고
    • Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2
    • Chang AC and Reddel RR. Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 1998; 141: 95-99.
    • (1998) Mol Cell Endocrinol , vol.141 , pp. 95-99
    • Chang, A.C.1    Reddel, R.R.2
  • 7
    • 11144316020 scopus 로고    scopus 로고
    • Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs
    • Gagliardi AD, Kuo EY, Raulic S, Wagner GF and DiMattia GE. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 2005; 288: E92-105.
    • (2005) Am J Physiol Endocrinol Metab , vol.288 , pp. E92-E105
    • Gagliardi, A.D.1    Kuo, E.Y.2    Raulic, S.3    Wagner, G.F.4    DiMattia, G.E.5
  • 8
    • 44949246247 scopus 로고    scopus 로고
    • Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
    • Raulic S, Ramos-Valdes Y and DiMattia GE. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro. J Endocrinol 2008; 197: 517-529.
    • (2008) J Endocrinol , vol.197 , pp. 517-529
    • Raulic, S.1    Ramos-Valdes, Y.2    DiMattia, G.E.3
  • 10
    • 70249090440 scopus 로고    scopus 로고
    • Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma
    • Volland S, Kugler W, Schweigerer L, Wilting J and Becker J. Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int J Cancer 2009; 125: 2049-2057.
    • (2009) Int J Cancer , vol.125 , pp. 2049-2057
    • Volland, S.1    Kugler, W.2    Schweigerer, L.3    Wilting, J.4    Becker, J.5
  • 13
    • 84899100112 scopus 로고    scopus 로고
    • Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
    • Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, Sang N and Pan J. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer Res 2014; 33: 26.
    • (2014) J Exp Clin Cancer Res , vol.33 , pp. 26
    • Lin, S.1    Guo, Q.2    Wen, J.3    Li, C.4    Lin, J.5    Cui, X.6    Sang, N.7    Pan, J.8
  • 14
    • 84880263393 scopus 로고    scopus 로고
    • Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy
    • Onal C, Reyhan M, Parlak C, Guler OC and Oymak E. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Int J Gynecol Cancer 2013; 23: 1104-1110.
    • (2013) Int J Gynecol Cancer , vol.23 , pp. 1104-1110
    • Onal, C.1    Reyhan, M.2    Parlak, C.3    Guler, O.C.4    Oymak, E.5
  • 15
    • 11144352119 scopus 로고    scopus 로고
    • Management of recurrent cervical cancer
    • Lai CH. Management of recurrent cervical cancer. Chang Gung Med J 2004; 27: 711-717.
    • (2004) Chang Gung Med J , vol.27 , pp. 711-717
    • Lai, C.H.1
  • 16
    • 84871416593 scopus 로고    scopus 로고
    • STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
    • Wang H, Wu K, Sun Y, Li Y, Wu M, Qiao Q, Wei Y, Han ZG and Cai B. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. BMB Rep 2012; 45: 629-634.
    • (2012) BMB Rep , vol.45 , pp. 629-634
    • Wang, H.1    Wu, K.2    Sun, Y.3    Li, Y.4    Wu, M.5    Qiao, Q.6    Wei, Y.7    Han, Z.G.8    Cai, B.9
  • 18
    • 72149117661 scopus 로고    scopus 로고
    • Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
    • Law AY and Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res 2010; 316: 466-476.
    • (2010) Exp Cell Res , vol.316 , pp. 466-476
    • Law, A.Y.1    Wong, C.K.2
  • 19
    • 84879028316 scopus 로고    scopus 로고
    • Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways
    • Law AY and Wong CK. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways. Mol Cell Endocrinol 2013; 374: 73-81.
    • (2013) Mol Cell Endocrinol , vol.374 , pp. 73-81
    • Law, A.Y.1    Wong, C.K.2
  • 21
    • 78149416513 scopus 로고    scopus 로고
    • Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
    • Law AY and Wong CK. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res 2010; 316: 3425-3434.
    • (2010) Exp Cell Res , vol.316 , pp. 3425-3434
    • Law, A.Y.1    Wong, C.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.